CMPX
Compass Therapeutics
$0.76
+$0.01 (+1.74%)Oct 28, 2026
Key metrics
The numbers that frame CMPX today
- Market cap
- $136.87M
- ROIC
- -44.3%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.73
- 52wk High
- $6.88
Growth
Revenue and earnings trend for CMPX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CMPX
Is Compass Therapeutics a good buy?
No. Compass Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Compass Therapeutics is selling at a very high price.
What is the market capitalization of CMPX?
Compass Therapeutics's market capitalization is $136.87M.
What is the 52-week high for CMPX stock?
The 52-week high for Compass Therapeutics is $6.88. The current close of $0.76 is 89% below that high.
What is the 52-week low for CMPX stock?
The 52-week low for Compass Therapeutics is $0.73. The current close of $0.76 is 4.1% above that low.
Does CMPX stock pay dividends?
Compass Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CMPX?
Compass Therapeutics's Debt / Equity ratio is 0.06.